Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review.

Bougea A, Anagnostou E, Spandideas N, Triantafyllou N, Kararizou E.

Einstein (Sao Paulo). 2015 Oct-Dec;13(4):627-35. doi: 10.1590/S1679-45082015RW3308. Epub 2015 Aug 21. Review. English, Portuguese.

2.

Spectrum of Eosinophilic End-Organ Manifestations.

Akuthota P, Weller PF.

Immunol Allergy Clin North Am. 2015 Aug;35(3):403-11. doi: 10.1016/j.iac.2015.04.002. Epub 2015 Jun 17. Review.

3.

[Eosinophilic fasciitis].

Niklas K, Niklas A, Puszczewicz M.

Postepy Hig Med Dosw (Online). 2015 Jan 2;69:488-95. Review. Polish.

4.

Anti-IL5 therapy for asthma and beyond.

Mukherjee M, Sehmi R, Nair P.

World Allergy Organ J. 2014 Dec 4;7(1):32. doi: 10.1186/1939-4551-7-32. eCollection 2014. Review.

5.

Myocardial Inflammation-Are We There Yet?

Greulich S, Ferreira VM, Dall'Armellina E, Mahrholdt H.

Curr Cardiovasc Imaging Rep. 2015;8(3):6. Review.

6.

Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.

Bonatti F, Reina M, Neri TM, Martorana D.

Front Immunol. 2014 Nov 17;5:577. doi: 10.3389/fimmu.2014.00577. eCollection 2014. Review.

7.

Montelukast-induced adverse drug reactions: a review of case reports in the literature.

Calapai G, Casciaro M, Miroddi M, Calapai F, Navarra M, Gangemi S.

Pharmacology. 2014;94(1-2):60-70. doi: 10.1159/000366164. Epub 2014 Sep 2. Review.

8.

The immunopathology of ANCA-associated vasculitis.

McKinney EF, Willcocks LC, Broecker V, Smith KG.

Semin Immunopathol. 2014 Jul;36(4):461-78. doi: 10.1007/s00281-014-0436-6. Epub 2014 Jul 24. Review.

9.

Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Khoury P, Grayson PC, Klion AD.

Nat Rev Rheumatol. 2014 Aug;10(8):474-83. doi: 10.1038/nrrheum.2014.98. Epub 2014 Jul 8. Review.

10.

Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.

Clain JM, Cartin-Ceba R, Fervenza FC, Specks U.

Ther Adv Musculoskelet Dis. 2014 Apr;6(2):58-74. doi: 10.1177/1759720X13516239. Review.

11.

Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature.

Tovoli F, Vannini A, Fusconi M, Frisoni M, Zauli D.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):136-41. Review.

12.

Biomarkers in vasculitis.

Monach PA.

Curr Opin Rheumatol. 2014 Jan;26(1):24-30. doi: 10.1097/BOR.0000000000000009. Review.

13.

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients.

Scichilone N, Battaglia S, Benfante A, Bellia V.

Clin Interv Aging. 2013;8:1329-37. doi: 10.2147/CIA.S35977. Epub 2013 Oct 2. Review.

14.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.

Vaglio A, Buzio C, Zwerina J.

Allergy. 2013 Mar;68(3):261-73. doi: 10.1111/all.12088. Epub 2013 Jan 18. Review.

15.
16.

Eosinophilic pneumonias.

Akuthota P, Weller PF.

Clin Microbiol Rev. 2012 Oct;25(4):649-60. doi: 10.1128/CMR.00025-12. Review.

17.

Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Amini-Vaughan ZJ, Martinez-Moczygemba M, Huston DP.

Curr Allergy Asthma Rep. 2012 Oct;12(5):402-12. doi: 10.1007/s11882-012-0290-3. Review.

18.

Churg-Strauss syndrome presenting with acute renal insufficiency accompanied by eosinophilic tubulointerstitial nephritis.

Hirohama D, Hoshino J, Sumida K, Hasegawa E, Hiramatsu R, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Takemoto F, Ubara Y, Hara S, Ohashi K, Takaichi K.

Intern Med. 2012;51(12):1555-60. Epub 2012 Jun 15. Review.

19.

Inhibition of interleukin-5 for the treatment of eosinophilic diseases.

Corren J.

Discov Med. 2012 Apr;13(71):305-12. Review.

20.

Vasculitis of the upper airways.

Pagnoux C, Wolter NE.

Swiss Med Wkly. 2012 Mar 19;142:w13541. doi: 10.4414/smw.2012.13541. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk